Literature DB >> 9337845

Rac1 is required for cell proliferation and G2/M progression.

K A Moore1, R Sethi, A M Doanes, T M Johnson, J B Pracyk, M Kirby, K Irani, P J Goldschmidt-Clermont, T Finkel.   

Abstract

We have transiently expressed a dominant negative form of rac1 (N17rac1) using adenoviral-mediated gene transfer. The level of N17rac1 expression is demonstrated to be proportional to the multiplicity of infection. Expression of N17rac1 in Rat 2 fibroblasts results in cytostatic growth arrest. Cell-cycle analysis demonstrates that cells expressing N17rac1 accumulate in G2/M. These results suggest that rac1 is required for cell proliferation and provide the first demonstration in mammalian cells of a role for small GTP-binding proteins in the G2/M transition.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9337845      PMCID: PMC1218631          DOI: 10.1042/bj3260017

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

Review 1.  Ras-related proteins.

Authors:  A Hall
Journal:  Curr Opin Cell Biol       Date:  1993-04       Impact factor: 8.382

2.  A rho-like protein is involved in the organisation of the contractile ring in dividing sand dollar eggs.

Authors:  I Mabuchi; Y Hamaguchi; H Fujimoto; N Morii; M Mishima; S Narumiya
Journal:  Zygote       Date:  1993-11       Impact factor: 1.442

3.  Cell-cycle calcium transients driven by cyclic changes in inositol trisphosphate levels.

Authors:  B Ciapa; D Pesando; M Wilding; M Whitaker
Journal:  Nature       Date:  1994-04-28       Impact factor: 49.962

Review 4.  Calcium, calmodulin and cell cycle regulation.

Authors:  A R Means
Journal:  FEBS Lett       Date:  1994-06-20       Impact factor: 4.124

5.  Ras proteins regulate multiple mitogenic pathways in A10 vascular smooth muscle cells.

Authors:  K Irani; S Herzlinger; T Finkel
Journal:  Biochem Biophys Res Commun       Date:  1994-08-15       Impact factor: 3.575

6.  Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.

Authors:  M Serrano; A W Lin; M E McCurrach; D Beach; S W Lowe
Journal:  Cell       Date:  1997-03-07       Impact factor: 41.582

7.  p120 GAP modulates Ras activation of Jun kinases and transformation.

Authors:  G J Clark; J K Westwick; C J Der
Journal:  J Biol Chem       Date:  1997-01-17       Impact factor: 5.157

8.  A human oncogene of the RAS superfamily unmasked by expression cDNA cloning.

Authors:  A M Chan; T Miki; K A Meyers; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-02       Impact factor: 11.205

9.  In vivo suppression of injury-induced vascular smooth muscle cell accumulation using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene.

Authors:  R J Guzman; E A Hirschowitz; S L Brody; R G Crystal; S E Epstein; T Finkel
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

10.  Multiple Ras functions can contribute to mammalian cell transformation.

Authors:  M A White; C Nicolette; A Minden; A Polverino; L Van Aelst; M Karin; M H Wigler
Journal:  Cell       Date:  1995-02-24       Impact factor: 41.582

View more
  31 in total

Review 1.  In search of "stemness".

Authors:  Jingli Cai; Mark L Weiss; Mahendra S Rao
Journal:  Exp Hematol       Date:  2004-07       Impact factor: 3.084

Review 2.  Redox modifier genes and pathways in amyotrophic lateral sclerosis.

Authors:  Barrie J Carter; Pervin Anklesaria; Stephanie Choi; John F Engelhardt
Journal:  Antioxid Redox Signal       Date:  2009-07       Impact factor: 8.401

3.  Protein kinase A-dependent and -independent signaling pathways contribute to cyclic AMP-stimulated proliferation.

Authors:  L A Cass; S A Summers; G V Prendergast; J M Backer; M J Birnbaum; J L Meinkoth
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

Review 4.  The diverse roles of Rac signaling in tumorigenesis.

Authors:  Natalie A Mack; Helen J Whalley; Sonia Castillo-Lluva; Angeliki Malliri
Journal:  Cell Cycle       Date:  2011-05-15       Impact factor: 4.534

5.  Anti-inflammatory cytokine interleukin-19 inhibits smooth muscle cell migration and activation of cytoskeletal regulators of VSMC motility.

Authors:  Khatuna Gabunia; Surbhi Jain; Ross N England; Michael V Autieri
Journal:  Am J Physiol Cell Physiol       Date:  2011-01-05       Impact factor: 4.249

6.  Protection from reoxygenation injury by inhibition of rac1.

Authors:  K S Kim; K Takeda; R Sethi; J B Pracyk; K Tanaka; Y F Zhou; Z X Yu; V J Ferrans; J T Bruder; I Kovesdi; K Irani; P Goldschmidt-Clermont; T Finkel
Journal:  J Clin Invest       Date:  1998-05-01       Impact factor: 14.808

7.  P-Rex1 is required for efficient melanoblast migration and melanoma metastasis.

Authors:  Colin R Lindsay; Samuel Lawn; Andrew D Campbell; William J Faller; Florian Rambow; Richard L Mort; Paul Timpson; Ang Li; Patrizia Cammareri; Rachel A Ridgway; Jennifer P Morton; Brendan Doyle; Shauna Hegarty; Mairin Rafferty; Ian G Murphy; Enda W McDermott; Kieran Sheahan; Katherine Pedone; Alexander J Finn; Pamela A Groben; Nancy E Thomas; Honglin Hao; Craig Carson; Jim C Norman; Laura M Machesky; William M Gallagher; Ian J Jackson; Leon Van Kempen; Friedrich Beermann; Channing Der; Lionel Larue; Heidi C Welch; Brad W Ozanne; Owen J Sansom
Journal:  Nat Commun       Date:  2011-11-22       Impact factor: 14.919

8.  HACE1 is a tumor suppressor gene candidate in natural killer cell neoplasms.

Authors:  Can Küçük; Xiaozhou Hu; Javeed Iqbal; Philippe Gaulard; David Klinkebiel; Adam Cornish; Bhavana J Dave; Wing C Chan
Journal:  Am J Pathol       Date:  2012-11-09       Impact factor: 4.307

9.  Cucurbitacin I inhibits Rac1 activation in breast cancer cells by a reactive oxygen species-mediated mechanism and independently of Janus tyrosine kinase 2 and P-Rex1.

Authors:  Cynthia Lopez-Haber; Marcelo G Kazanietz
Journal:  Mol Pharmacol       Date:  2013-03-11       Impact factor: 4.436

10.  SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model.

Authors:  Maged M Harraz; Jennifer J Marden; Weihong Zhou; Yulong Zhang; Aislinn Williams; Victor S Sharov; Kathryn Nelson; Meihui Luo; Henry Paulson; Christian Schöneich; John F Engelhardt
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.